NORML
OCTOBER 21, 2019
Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications.
Canna Law Blog
JUNE 1, 2019
Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. Here’s what John Erlichman, a key aid to then-President Nixon, told Harper’s Magazine in 2016: You want to know what this was really all about? You understand what I’m saying?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
WeedAdvisor
AUGUST 28, 2019
The applications were submitted as far back as 2016. Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. This likely would have been longer, but the DEA had not anticipated a legal threat to force some action. Dozens of Applications”. .
Cannabis Law Report
SEPTEMBER 9, 2019
The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.
United Patients Group
APRIL 3, 2023
Epidiolex, an FDA-approved medication containing CBD (cannabidiol), has been listed as Schedule 5 by the DEA since June 25th, 2019. A cannabis recommendation is an assessment of your medical history and current condition by an appropriate health care professional. or some naturopathic doctors who are licensed in their jurisdiction.
The Blunt Truth
JUNE 6, 2019
The Blunt Truth started in February 2016, with the slightly crazy idea that a BigLaw firm could talk about marijuana on a regular basis. Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. F irst, a point of personal pride. As of this week, we’ve reached our 300th post.
Cannabis Law Report
APRIL 1, 2019
The following are highlights of this historic agreement: SIVA will exclusively handle the rewrite of the Controlled Substances Act (CSA), with limited involvement allowed from the different federal agencies, including the FDA, DEA, etc. You’ll find his past employment history but nothing about educational background.
Expert insights. Personalized for you.
104 
Let's personalize your content